Cambridge Investment Research Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.26M | Buy |
|
|||||
|
2025
Q2 | $2.05M | Sell |
|
|||||
|
2025
Q1 | $2.49M | Sell |
|
|||||
|
2024
Q4 | $3.08M | Sell |
|
|||||
|
2024
Q3 | $5.62M | Buy |
|
|||||
|
2024
Q2 | $5.45M | Sell |
|
|||||
|
2024
Q1 | $5.04M | Sell |
|
|||||
|
2023
Q4 | $7.13M | Sell |
|
|||||
|
2023
Q3 | $8.33M | Buy |
|
|||||
|
2023
Q2 | $3.08M | Sell |
|
|||||
|
2023
Q1 | $4.75M | Sell |
|
|||||
|
2022
Q4 | $4.63M | Sell |
|
|||||
|
2022
Q3 | $4.91M | Sell |
|
|||||
|
2022
Q2 | $5.71M | Sell |
|
|||||
|
2022
Q1 | $6.94M | Sell |
|
|||||
|
2021
Q4 | $6.68M | Buy |
|
|||||
|
2021
Q3 | $6.1M | Sell |
|
|||||
|
2021
Q2 | $6.65M | Buy |
|
|||||
|
2021
Q1 | $5.43M | Sell |
|
|||||
|
2020
Q4 | $6.63M | Buy |
|
|||||
|
2020
Q3 | $6.1M | Sell |
|
|||||
|
2020
Q2 | $9.28M | Buy |
|
|||||
|
2020
Q1 | $4.04M | Sell |
|
|||||
|
2019
Q4 | $4.49M | Buy |
|
|||||
|
2019
Q3 | $3.27M | Sell |
|
|||||
|
2019
Q2 | $4.15M | Buy |
|
|||||
|
2019
Q1 | $5.44M | Buy |
|
|||||
|
2018
Q4 | $4.76M | Buy |
|
|||||
|
2018
Q3 | $4.56M | Sell |
|
|||||
|
2018
Q2 | $4.12M | Buy |
|
|||||
|
2018
Q1 | $3.95M | Buy |
|
|||||
|
2017
Q4 | $3.5M | Buy |
|
|||||
|
2017
Q3 | $4.04M | Buy |
|
|||||
|
2017
Q2 | $1.31M | Sell |
|
|||||
|
2017
Q1 | $1.08M | Buy |
|
|||||
|
2016
Q4 | $926K | Sell |
|
|||||
|
2016
Q3 | $1.06M | Sell |
|
|||||
|
2016
Q2 | $959K | Buy |
|
|||||
|
2016
Q1 | $767K | Sell |
|
|||||
|
2015
Q4 | $1.2M | Buy |
|
|||||
|
2015
Q3 | $1.01M | Buy |
|
|||||
|
2015
Q2 | $498K | Sell |
|
|||||
|
2015
Q1 | $640K | Buy |
|
|||||
|
2014
Q4 | $559K | Sell |
|
|||||
|
2014
Q3 | $529K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $243K | Buy |
|